UBS Maintains Buy on Teradyne, Raises Price Target to $440

Benzinga Newsdesk www.benzinga.com Positive 81.4%

Neg 0% Neu 0% Pos 81.4%

UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $325 to $440.

Comments

No comments yet. Be the first!